Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al.

Alzheimer's and Dementia

Volumn 11, Issue 9, 2015, Pages 1123-1124

  Diomedi, Marina ^a   Stefani, Alessandro ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CEREBROSPINAL FLUID ANALYSIS; DOPPLER FLOWMETRY; EARLY DIAGNOSIS; HEMODYNAMICS; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BRAIN; CEREBROSPINAL FLUID; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; HUMANS; PEPTIDE FRAGMENTS;

EID: 84942198410     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.10.004     Document Type: Letter

References (10)

1. S. Lista, F.G. Garaci, M. Ewers, S. Teipel, H. Zetterberg, K. Blennow, and et al. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease Alzheimers Dement 10 2014 381 392
2. A.S. Khachaturian, M.M. Mielke, and Z.S. Khachaturian Biomarker development: a population-level perspective Alzheimers Dement 8 2012 247 249
3. M. Diomedi, and G. Misaggi Vascular contribution to Alzheimer disease: predictors of rapid progression CNS Neurol Disord Drug Targets 12 2013 532 537
4. K. Buerger, O. Uspenskaya, O. Hartmann, O. Hansson, L. Minthon, K. Blennow, and et al. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio Biol Psychiatry 65 2009 979 984
5. M. Silvestrini, P. Pasqualetti, R. Baruffaldi, M. Bartolini, Y. Handouk, M. Matteis, and et al. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease Stroke 37 2006 1010 1015
6. A.E. Roher, Z. Garami, S.L. Tyas, C.L. Maarouf, T.A. Kokjohn, M. Belohlavek, and et al. Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease Alzheimers Dement 7 2011 445 455
7. A. Stefani, G. Sancesario, M. Pierantozzi, G. Leone, S. Galati, A.H. Hainsworth, and et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia J Neurol Sci 283 2009 109 115
8. K. Lobello, J.M. Ryan, E. Liu, G. Rippon, and R. Black Targeting beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease Int J Alzheimers Dis 2012 2012 628070 Article ID
9. N. Mattsson, U. Andreasson, S. Persson, H. Arai, S.D. Batish, S. Bernardini, and et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers Alzheimers Dement 7 2011 386 395
10. K. Buerger, O. Uspenskaya, O. Hartmann, O. Hansson, L. Minthon, K. Blennow, and et al. Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment J Clin Psychiatry 72 2011 556 563